ConductScience.org, home

Trial · NCT03340064

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
First PeriodSTARTEDLevetiracetam: Adjunctive Therapy32
First PeriodSTARTEDLevetiracetam: Monotherapy6
First PeriodCOMPLETEDLevetiracetam: Adjunctive Therapy27
First PeriodCOMPLETEDLevetiracetam: Monotherapy6
First PeriodNOT COMPLETEDLevetiracetam: Adjunctive Therapy5
First PeriodNOT COMPLETEDLevetiracetam: Monotherapy0
Second PeriodSTARTEDLevetiracetam: Adjunctive Therapy27
Second PeriodSTARTEDLevetiracetam: Monotherapy6
Second PeriodCOMPLETEDLevetiracetam: Adjunctive Therapy8
Second PeriodCOMPLETEDLevetiracetam: Monotherapy4
Second PeriodNOT COMPLETEDLevetiracetam: Adjunctive Therapy19
Second PeriodNOT COMPLETEDLevetiracetam: Monotherapy2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03340064/flow